{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:03:54Z","timestamp":1791313434334,"version":"4.3.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10096-007-0455-5","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T05:22:17Z","timestamp":1200979337000},"page":"433-437","source":"Crossref","is-referenced-by-count":86,"title":["High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia"],"prefix":"10.1007","volume":"27","author":[{"given":"M.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"455_CR1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/383472","volume":"38","author":"CF Carpenter","year":"2004","unstructured":"Carpenter CF, Chambers HF (2004) Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 38:994\u20131000","journal-title":"Clin Infect Dis"},{"key":"455_CR2","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing: 16th information supplement. CLSI document M100\u2013S16, National Committee for Clinical Laboratory Standards (NCCLS), Wayne, PA"},{"key":"455_CR3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355:653\u2013665","journal-title":"N Engl J Med"},{"key":"455_CR4","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","volume":"43","author":"MK Hayden","year":"2005","unstructured":"Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA (2005) Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:5285\u20135287","journal-title":"J Clin Microbiol"},{"key":"455_CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","volume":"27","author":"D Hirschwerk","year":"2006","unstructured":"Hirschwerk D, Ginocchio GC, Bythrow M, Condon S (2006) Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 27:315\u2013317","journal-title":"Infect Control Hosp Epidemiol"},{"key":"455_CR6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","volume":"40","author":"A Mangili","year":"2005","unstructured":"Mangili A, Bica I, Snydman DR, Hamer DH (2005) Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 40:1058\u20131060","journal-title":"Clin Infect Dis"},{"key":"455_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","volume":"44","author":"FM Marty","year":"2006","unstructured":"Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK (2006) Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 44:595\u2013597","journal-title":"J Clin Microbiol"},{"key":"455_CR8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","volume":"44","author":"DJ Skiest","year":"2006","unstructured":"Skiest DJ (2006) Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 44:655\u2013656","journal-title":"J Clin Microbiol"},{"key":"455_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633\u2013638","journal-title":"Clin Infect Dis"},{"key":"455_CR10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233\u20132239","journal-title":"J Clin Microbiol"},{"key":"455_CR11","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","volume":"43","author":"K Zhang","year":"2005","unstructured":"Zhang K, McClure J, Elsayed S, Louie T, Conly JM (2005) Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43:5026\u20135033","journal-title":"J Clin Microbiol"},{"key":"455_CR12","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/491713","volume":"42","author":"G Sakoulas","year":"2006","unstructured":"Sakoulas G, Mollering RC Jr, Eliopoulos GM (2006) Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis 42:S40\u2013S50","journal-title":"Clin Infect Dis"},{"key":"455_CR13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","volume":"50","author":"L Friedman","year":"2006","unstructured":"Friedman L, Alder JD, Silverman JA (2006) Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50:2137\u20132145","journal-title":"Antimicrob Agents Chemother"},{"key":"455_CR14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","volume":"42","author":"JB Patel","year":"2006","unstructured":"Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC (2006) An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis 42:1652\u20131653","journal-title":"Clin Infect Dis"},{"key":"455_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","volume":"41","author":"L Cui","year":"2003","unstructured":"Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5\u201314","journal-title":"J Clin Microbiol"},{"key":"455_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijantimicag.2006.05.030","volume":"28","author":"GW Kaatz","year":"2006","unstructured":"Kaatz GW, Lundstrom TS, Seo SM (2006) Mechanisms of daptomycin resistance in Staphylococcus aureus. Int J Antimicrob Agents 28:280\u2013287","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0455-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0455-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T22:41:09Z","timestamp":1588286469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0455-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}